Doximity, Inc. $DOCS Stock Position Raised by Quantbot Technologies LP

Quantbot Technologies LP raised its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 182.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 212,868 shares of the company’s stock after acquiring an additional 137,541 shares during the quarter. Quantbot Technologies LP’s holdings in Doximity were worth $12,353,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. VSM Wealth Advisory LLC purchased a new position in Doximity during the 1st quarter valued at about $29,000. Allworth Financial LP grew its stake in Doximity by 104.0% during the 1st quarter. Allworth Financial LP now owns 563 shares of the company’s stock valued at $32,000 after acquiring an additional 287 shares in the last quarter. National Bank of Canada FI purchased a new position in Doximity during the 1st quarter valued at about $33,000. Spire Wealth Management grew its stake in Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company’s stock valued at $36,000 after acquiring an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group grew its stake in Doximity by 70.7% during the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock valued at $43,000 after acquiring an additional 309 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Performance

DOCS opened at $65.12 on Monday. Doximity, Inc. has a twelve month low of $34.34 and a twelve month high of $85.21. The firm has a market cap of $12.20 billion, a P/E ratio of 65.12, a price-to-earnings-growth ratio of 4.10 and a beta of 1.36. The business has a 50 day moving average price of $60.02 and a 200 day moving average price of $60.27.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same quarter last year, the firm earned $0.28 earnings per share. The company’s quarterly revenue was up 15.2% compared to the same quarter last year. As a group, analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Buying and Selling at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director directly owned 16,618 shares of the company’s stock, valued at $948,721.62. This represents a 10.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Regina M. Benjamin sold 5,000 shares of the stock in a transaction on Friday, August 8th. The shares were sold at an average price of $63.00, for a total transaction of $315,000.00. Following the completion of the sale, the director directly owned 16,618 shares of the company’s stock, valued at approximately $1,046,934. This trade represents a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 36,000 shares of company stock valued at $2,140,940 in the last ninety days. Company insiders own 31.30% of the company’s stock.

Wall Street Analysts Forecast Growth

DOCS has been the topic of several research analyst reports. The Goldman Sachs Group set a $50.00 target price on Doximity and gave the company a “neutral” rating in a research note on Wednesday, May 21st. Piper Sandler raised their price objective on shares of Doximity from $65.00 to $69.00 and gave the company an “overweight” rating in a research report on Monday, August 11th. BTIG Research raised shares of Doximity from a “neutral” rating to a “buy” rating and set a $80.00 target price for the company in a research report on Monday, June 2nd. Canaccord Genuity Group increased their price target on shares of Doximity from $50.00 to $59.00 and gave the stock a “hold” rating in a research note on Friday, August 8th. Finally, Robert W. Baird dropped their price target on shares of Doximity from $87.00 to $65.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. Ten research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Doximity presently has a consensus rating of “Moderate Buy” and an average price target of $66.21.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.